NCT05469412

Brief Summary

The purpose of this study is to find out any beneficial effects of electronic devices over preoperative pharmacological intervention in the preoperative period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 13, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 21, 2022

Completed
8 months until next milestone

Study Start

First participant enrolled

March 20, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 25, 2024

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2024

Completed
Last Updated

June 26, 2024

Status Verified

June 1, 2024

Enrollment Period

1 year

First QC Date

June 13, 2022

Last Update Submit

June 25, 2024

Conditions

Keywords

Preoperative Anxiety

Outcome Measures

Primary Outcomes (1)

  • modified Yale Preoperative Anxiety Scale

    The instrument contains 27 items in 5 categories that indicate preoperative anxiety in children: activity, emotional expressivity, state of arousal, vocalization, and use of parents. Scores range from 23.33 to 100, with higher values indicating higher anxiety.

    Day 1

Study Arms (2)

Interventional group

EXPERIMENTAL

Standard management combined with distraction by using technology (Tablets/iPads).

Device: iPad®

Control group

ACTIVE COMPARATOR

Standard management combined with pharmacological intervention (oral midazolam 0.5 mg/kg) administered at least 30 min before surgery (maximum 20mg).

Drug: Midazolam

Interventions

iPad®DEVICE

Use of Technology.

Also known as: Tablet
Interventional group

Standard management combined with pharmacological intervention (oral midazolam 0.5 mg/kg) administered at least 30 min before surgery (maximum 20mg).

Control group

Eligibility Criteria

Age2 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Children aged between 2 and 12 years old
  • ASA I and II
  • Informed consent signed by parents or legal guardians

You may not qualify if:

  • Previous exposure to surgery
  • Contraindication to midazolam
  • Patients with developmental delay
  • Patients with significant visual/hearing problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aga Khan University Hospital

Karachi, Sindh, Pakistan

Location

Related Publications (3)

  • Manyande A, Cyna AM, Yip P, Chooi C, Middleton P. Non-pharmacological interventions for assisting the induction of anaesthesia in children. Cochrane Database Syst Rev. 2015 Jul 14;2015(7):CD006447. doi: 10.1002/14651858.CD006447.pub3.

    PMID: 26171895BACKGROUND
  • Agbayani CG, Fortier MA, Kain ZN. Non-pharmacological methods of reducing perioperative anxiety in children. BJA Educ. 2020 Dec;20(12):424-430. doi: 10.1016/j.bjae.2020.08.003. Epub 2020 Oct 21. No abstract available.

    PMID: 33456927BACKGROUND
  • Cheng X, Chen Z, Zhang L, Xu P, Qin F, Jiao X, Wang Y, Lin M, Zeng L, Huang L, Yu D. Efficacy and Safety of Midazolam Oral Solution for Sedative Hypnosis and Anti-anxiety in Children: A Systematic Review and Meta-Analysis. Front Pharmacol. 2020 Mar 18;11:225. doi: 10.3389/fphar.2020.00225. eCollection 2020.

    PMID: 32256348BACKGROUND

MeSH Terms

Conditions

Anxiety Disorders

Interventions

Vaginal Creams, Foams, and JelliesMidazolam

Condition Hierarchy (Ancestors)

Mental Disorders

Intervention Hierarchy (Ancestors)

Dosage FormsPharmaceutical PreparationsFeminine Hygiene ProductsEquipment and SuppliesBenzodiazepinesBenzazepinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 13, 2022

First Posted

July 21, 2022

Study Start

March 20, 2023

Primary Completion

March 25, 2024

Study Completion

April 1, 2024

Last Updated

June 26, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations